Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Study of POBA Versus Cotavance Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia

NCT01260870 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01260870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01260870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Study of POBA Versus Cotavance Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Terminated
Start date
August 15, 2011
Completion date
July 15, 2013
Enrollment
44 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

infrapopliteal lesions, pad